UNP vs ZBIO · P/E 21, rev $6.86B vs rev $10.0M
Union Pacific Corporation (UNP) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
UNP currently screens at market cap $153.21B and trailing P/E 21.3. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the UNP and ZBIO stock pages for the full models.
Not investment advice.